ARCA biopharma, Inc.
METHODS AND COMPOSITIONS INVOLVING (S)-BUCINDOLOL

Last updated:

Abstract:

Disclosed is bucindolol substantially free of its R-stereoisomer. Also disclosed are pharmaceutical compositions that include bucindolol substantially free of its R-stereoisomer or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. Also disclosed are methods of treating a patient that involve administering to the patient a therapeutically effective amount of a composition of the present invention.

Status:
Application
Type:

Utility

Filling date:

13 Dec 2018

Issue date:

28 Nov 2019